Literature DB >> 21136171

The polymorphisms of the TNF-α gene in multiple sclerosis?--a meta-analysis.

Lidan Xu1, Weiguang Yuan, Haiming Sun, Xuelong Zhang, Xueyuan Jia, Chao Shen, Yanling Zhao, Donglin Sun, Yang Yu, Yan Jin, Songbin Fu.   

Abstract

The association between multiple sclerosis (MS) and tumor necrosis factor-alpha gene (TNF-α) polymorphisms has been analyzed in several studies, but conflicting results have been reported. The main purpose of this study was to integrate previous findings and explore whether the three single nucleotide polymorphisms (SNPs; -238G/A, -308G/A, and -376G/A) of TNF-α are associated with susceptibility to MS. A total of 2,639 patients and 3,303 controls from 21 studies, which were identified by searching the ISI Web of Knowledge database and the PubMed database up to December 2009, were collected for this meta-analysis. The association between MS and TNF-α -238G/A, -308G/A, and -376G/A was previously analyzed in 4, 18, and 4 studies, respectively. Overall, no associations were identified for the TNF-α -238G/A polymorphism and MS in any of genetic model. Similarly, no associations were found for the TNF-α -308G/A polymorphism and MS or between the TNF-α -376G/A polymorphism and MS. Furthermore, no significant association between the three SNPs and MS was identified using subgroup analyses examining ethnicity and clinical manifestation. The results of the present study indicated that TNF-α -238G/A, -308G/A, or -376G/A may not be the main risk factor for MS, which should be interpret with caution for the limited study numbers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136171     DOI: 10.1007/s11033-010-0533-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis.

Authors:  D Wingerchuk; Q Liu; J Sobell; S Sommer; B G Weinshenker
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis.

Authors:  B G Weinshenker; D M Wingerchuk; Q Liu; A S Bissonet; D J Schaid; S S Sommer
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients.

Authors:  T W Huizinga; R G Westendorp; E L Bollen; V Keijsers; B M Brinkman; J A Langermans; F C Breedveld; C L Verweij; L van de Gaer; L Dams; J B Crusius; A García-Gonzalez; B W van Oosten; C H Polman; A S Peña
Journal:  J Neuroimmunol       Date:  1997-02       Impact factor: 3.478

5.  TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients.

Authors:  G Lucotte; C Bathelier; G Mercier
Journal:  Mult Scler       Date:  2000-04       Impact factor: 6.312

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis.

Authors:  M Fernandez-Arquero; R Arroyo; A Rubio; C Martin; P Vigil; L Conejero; M A Figueredo; E G de la Concha
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

8.  Influence of TNFalpha gene polymorphisms on TNFalpha production and disease.

Authors:  A H Hajeer; I V Hutchinson
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?

Authors:  Marcelo A Kauffman; Dolores González Morón; Gustavo Sandoval; Roberto E Sica; Orlando Garcea; Andrés M Villa
Journal:  Medicina (B Aires)       Date:  2007       Impact factor: 0.653

View more
  5 in total

1.  Interaction of HLA-DRB1*1501 and TNF-Alpha in a Population-based Case-control Study of Multiple Sclerosis.

Authors:  Dhelia M Williamson; Ruth Ann Marrie; Allison Ashley-Koch; Glen A Satten
Journal:  Immunol Infect Dis       Date:  2013-09

Review 2.  Monoclonal antibody therapy-associated neurological disorders.

Authors:  Xavier Bosch; Albert Saiz; Manuel Ramos-Casals
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

3.  Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.

Authors:  Antos Shakhbazau; Geert J Schenk; Curtis Hay; Jean Kawasoe; Roel Klaver; V Wee Yong; Jeroen J G Geurts; Jan van Minnen
Journal:  Mol Biol Rep       Date:  2016-04-26       Impact factor: 2.316

4.  Association of Polymorphisms in Inflammatory Cytokines Encoding Genes With Anti-N-methyl-D-Aspartate Receptor Encephalitis in the Southern Han Chinese.

Authors:  Xing Li; Jiajia Zhu; Yu Peng; Hongbing Guan; Jinyu Chen; Zhanhang Wang; Dong Zheng; Nan Cheng; Honghao Wang
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

5.  Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis.

Authors:  Denize Atan; Jarka Heissigerova; Lucia Kuffová; Aideen Hogan; Dara J Kilmartin; John V Forrester; Jeff L Bidwell; Andrew D Dick; Amanda J Churchill
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.